Agios Pharmaceuticals Inc 2025 Sustainability Report
Company: Agios Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: Sustainability Report
Pages: 42
The report highlights Agios' 2025 U.S. approval of AQVESME (mitapivat) for adults with thalassemia, expanded patient access through multicultural education and language-support programs, and environmental initiatives including glass recycling, waste auditing, and a Green Chemistry resources hub.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.